Rithm Capital Valuation
Is 14N1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 14N1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 14N1 (€10.43) is trading below our estimate of fair value (€21.58)
Significantly Below Fair Value: 14N1 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 14N1?
Other financial metrics that can be useful for relative valuation.
| What is 14N1's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$5.38b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | -2.7x |
Price to Earnings Ratio vs Peers
How does 14N1's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 39.6x | ||
DWS DWS Group GmbH KGaA | 14.2x | 13.2% | €7.9b |
ARLN Aareal Bank | 13.7x | 24.6% | €2.0b |
ARLN Aareal Bank | 48.2x | n/a | €2.0b |
HYQ Hypoport | 82.6x | 31.8% | €1.7b |
14N1 Rithm Capital | 7.3x | -2.8% | €5.4b |
Price-To-Earnings vs Peers: 14N1 is good value based on its Price-To-Earnings Ratio (7.3x) compared to the peer average (39.6x).
Price to Earnings Ratio vs Industry
How does 14N1's PE Ratio compare vs other companies in the Global Mortgage REITs Industry?
Price-To-Earnings vs Industry: 14N1 is good value based on its Price-To-Earnings Ratio (7.3x) compared to the Global Mortgage REITs industry average (11x).
Price to Earnings Ratio vs Fair Ratio
What is 14N1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 7.3x |
| Fair PE Ratio | 13.1x |
Price-To-Earnings vs Fair Ratio: 14N1 is good value based on its Price-To-Earnings Ratio (7.3x) compared to the estimated Fair Price-To-Earnings Ratio (13.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €10.43 | €11.50 +10.3% | 7.2% | €12.65 | €9.84 | n/a | 11 |
| Apr ’25 | €10.28 | €11.15 +8.5% | 7.1% | €11.90 | €9.61 | n/a | 11 |
| Mar ’25 | €10.08 | €11.11 +10.2% | 6.5% | €11.99 | €9.68 | n/a | 11 |
| Feb ’25 | €9.77 | €11.00 +12.6% | 6.3% | €11.96 | €9.66 | n/a | 10 |
| Jan ’25 | €9.60 | €10.96 +14.2% | 6.3% | €12.08 | €9.76 | n/a | 10 |
| Dec ’24 | €9.66 | €10.81 +11.9% | 6.4% | €11.99 | €9.68 | n/a | 9 |
| Nov ’24 | €8.97 | €11.18 +24.6% | 6.4% | €12.40 | €10.01 | n/a | 9 |
| Oct ’24 | €8.76 | €10.87 +24.1% | 6.7% | €12.17 | €9.83 | n/a | 9 |
| Sep ’24 | €9.63 | €10.61 +10.2% | 6.6% | €11.94 | €9.64 | n/a | 10 |
| Aug ’24 | €9.15 | €10.31 +12.6% | 7.3% | €11.75 | €9.04 | n/a | 10 |
| Jul ’24 | €8.53 | €10.28 +20.5% | 7.8% | €11.88 | €9.14 | n/a | 10 |
| Jun ’24 | €7.67 | €10.39 +35.5% | 9.4% | €12.12 | €8.39 | n/a | 10 |
| May ’24 | €7.36 | €10.19 +38.5% | 10.0% | €11.85 | €8.20 | €10.43 | 11 |
| Apr ’24 | €7.35 | €10.57 +43.8% | 7.8% | €11.99 | €9.23 | €10.28 | 11 |
| Mar ’24 | €8.46 | €10.67 +26.2% | 7.8% | €12.11 | €9.32 | €10.08 | 11 |
| Feb ’24 | €8.62 | €10.68 +23.9% | 9.4% | €12.21 | €8.46 | €9.77 | 11 |
| Jan ’24 | €7.64 | €10.72 +40.3% | 9.4% | €12.26 | €8.49 | €9.60 | 11 |
| Dec ’23 | €8.60 | €11.08 +28.9% | 9.7% | €12.69 | €8.79 | €9.66 | 10 |
| Nov ’23 | €8.56 | €11.96 +39.7% | 9.6% | €13.29 | €9.20 | €8.97 | 10 |
| Oct ’23 | €7.44 | €12.14 +63.2% | 9.2% | €13.27 | €9.18 | €8.76 | 10 |
| Sep ’23 | €9.14 | €11.80 +29.1% | 7.0% | €12.79 | €9.84 | €9.63 | 10 |
| Aug ’23 | €10.59 | €12.13 +14.6% | 8.7% | €13.76 | €9.83 | €9.15 | 10 |
| Jul ’23 | €9.13 | €12.03 +31.8% | 9.1% | €13.53 | €9.50 | €8.53 | 10 |
| Jun ’23 | €10.59 | €12.16 +14.9% | 6.1% | €13.46 | €10.86 | €7.67 | 10 |
| May ’23 | €9.81 | €11.70 +19.3% | 4.4% | €12.44 | €10.60 | €7.36 | 10 |
Analyst Forecast: Target price is less than 20% higher than the current share price.